Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery

References

• Johns KJ, O’Day DM. Pharmacologic management of keratomycosis. Surv Ophthalmol 1988;33:178–188
   PubMed Web of Science ®Google Scholar
• O’Day DM. Selection of appropriate antifungal therapy. Cornea 1987;6:238–245
   PubMed Web of Science ®Google Scholar
• Jones DB. Decision making in the management of microbial keratitis. Ophthalmology 1981;88:814–820
   PubMed Web of Science ®Google Scholar
• Forster RK. The cornea scientific foundation and clinical practice. Boston, MA: Little Brown & Co; 1987:228–240
   Google Scholar
• Richardson K, Brammer KW, Marriott MS. Activity of UK49, 858, a bis-triazole derivative against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob Agents Chemother 1985;27:832–835
   PubMed Web of Science ®Google Scholar
• Dupont B, Drouhet E. Early experience with itraconazole in vitro and in patients. Pharmacokinetic studies and clinical results. Rev Infect Dis (Suppl) 1987;9:S71–S76
   PubMedGoogle Scholar
• Davies N. Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol 2000;27:558–562
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–177
   PubMed Web of Science ®Google Scholar
• Muller RH, Souto EB, Radtke M. Nanostructured lipid carriers. A novel generation of solid lipid drug carriers. Pharm Technol Eur 2005;17:45–50
   Google Scholar
• Ravi Kumar MN. Nano and microparticles as controlled drug delivery devices. J Pharm Pharm Sci 2000;3:234–258
   PubMed Web of Science ®Google Scholar
• Muller RH, Maassen S, Weyhers H, Mehnert W. Phagocytic uptake and cytotoxicity of solid lipid nano-particles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target 1996;4:161–170
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011;12:62–76
   PubMed Web of Science ®Google Scholar
• Yuan H, Huang LF, Du YZ, et al. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces 2008;61:132–137
   PubMed Web of Science ®Google Scholar
• Xie S, Zhu L, Dong Z, et al. Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids. Colloids Surf B Biointerfaces 2011;83:382–387
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278–287
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Shaw J, Al-Kassas R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv 2010;17:467–489
   PubMed Web of Science ®Google Scholar
• Malhotra M, Majumdar DK. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops. Indian J Exp Biol 1997;35:941–947
   PubMedGoogle Scholar
• Venkateswarlu V, Manjunath K. Preparation characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 2004;95:627–638
   PubMed Web of Science ®Google Scholar
• Hao J, Fang X, Zhou Y, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box–Behnken design. Int J Nanomed 2011;6:683–692
   PubMed Web of Science ®Google Scholar
• Silverman RB. The organic chemistry of drug design and drug action. New York (NY): Elsevier; 2004:55–61
   Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. Somerset: Butler & Tanner; 2006:308–310
   Google Scholar
• Siekmann B, Westesen K. Submicron sized parentral carrier systems based on solid lipids. Pharm Pharmacol Lett 1992;1:123–126
   Google Scholar
• Varshosaz J, Minayian M, Moazen E. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. J Liposome Res 2010;20:115–123
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Fessi H. A pilot study of freeze-drying of poly (epsilon-caprolactone) nanocapsules stabilized by poly (vinyl alcohol): formulation and process optimization. Int J Pharm 2006;309:178–188
   PubMed Web of Science ®Google Scholar
• Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J Control Release 2008;127:97–109
   PubMed Web of Science ®Google Scholar
• Heiati H, Tawashi R, Shivers RR, Phillipps NC. Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate. Int J Pharm 1997;146:123–131
   Web of Science ®Google Scholar
• Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 2007;337:299–306
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. Solid lipid nanoparticles loaded with insulin by sodium cholatephosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 2007;340:153–162
   PubMed Web of Science ®Google Scholar
• Walstra P. Encyclopedia of emulsion technology. 4th ed. Becher P, ed. New York: Marcel Dekker; 1996:1–62
   Google Scholar
• Huang ZR, Hua SC, Yang YL, Fang JY. Development and evaluation of lipid naoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin 2008;29:1094–1102
   PubMed Web of Science ®Google Scholar
• Yuan H, Miao J, Du YZ, et al. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 2008;348:137–145
   PubMed Web of Science ®Google Scholar
• K. Westesen. Particles with modified physico-chemical properties, their preparation and uses, US Patent 6; 2001, 197, 349
   Google Scholar
• Li Y, Dong L, Jia A, et al. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromol 2006;38:296–299
   PubMed Web of Science ®Google Scholar
• Maurice DM, Riley MV. Ocular pharmacokinetics. In: Graymore CN, ed. Biochemistry of the eye. London: Academic Press; 1970:6–16
   Google Scholar
• Schoenwald RD, Huang HS. Corneal penetration behavior of beta-blocking agents. I. Physicochemical factors. J Pharm Sci 1983;72:1266–1272
   PubMed Web of Science ®Google Scholar